Receptor mechanisms involved in the anticonvulsant effect of melatonin in maximal electroshock seizures

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 26, Issue 3, 2004, Pages 177-181

  Ray, M ^a   Mediratta, P K ^a   Reeta, Kh ^a   Mahajan, P ^a   Sharma, K K ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

GABAergic mechanism; Maximal electroshock seizures; Melatonin; Serotonergic mechanism

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; BICUCULLINE; BUSPIRONE; CARBAMAZEPINE; DIAZEPAM; LAMOTRIGINE; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; MIANSERIN; ONDANSETRON; PRAZOSIN; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ELECTRIC SHOCK; GABAERGIC SYSTEM; HINDLIMB; MALE; MOUSE; NONHUMAN; SEIZURE; SEROTONINERGIC SYSTEM;

ANIMALS; ANTICONVULSANTS; ELECTROSHOCK; MALE; MELATONIN; MICE; RECEPTORS, GABA-A; RECEPTORS, MELATONIN; RECEPTORS, SEROTONIN; SEIZURES;

EID: 2442597298     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2004.26.3.809723     Document Type: Article

References (29)

1. Borjigin, J., Xiaodong, L., Snyder, S.H. The pineal gland and melatonin: Molecular and pharmacologic regulation. Annu Rev Pharmacol Toxicol 1999, 39: 53-65.
2. Dubocovich, M.L. Melatonin receptors: Are there multiple subtypes? Trends Pharmacol Sci 1995, 16: 50-6.
3. Barrett, P., Morris, M., Choi, W.S., Ross, A., Morgan, P.J. Melatonin receptors and signal transduction mechanisms. Biol Signals Recept 1999, 8: 6-14.
4. Borowicz, K.K., Kaminski, R., Gasior, M., Kleinrock, Z., Czurzwar, S.J. Influence of melatonin upon the protective action of conventional antiepileptic drugs against maximal electroshock in mice. Eur Neuropsychopharmacol 1999, 9: 185-90.
5. Rosenstein, R.E., Cardiali, D.P. Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Res 1986, 398: 403-6.
6. Gale, K. GABA and epilepsy: Basic concepts from preclinical research. Epilepsia 1992, 33: S3-12.
7. A receptor channels. Annu Rev Neurosci 1994, 17: 569-602.
8. th edition. Hardman, J.G., Limbird, L.E., Goodman, A.G. (Eds.). Mc Graw Hill: New York 2001, 274-90.
9. Gaffori, O., Van Ree, J.M. Serotonin and antidepressant drugs antagonize melatonin-induced behavioral changes after injection into the nucleus accumbens of rats. Neuropharmacology 1985, 24: 237-44.
10. Steardo, L., Monteleone, P., Trabace, L., Cannizaro, C., Maj, M., Cuomo, V. Serotonergic modulation of rat pineal gland: In vivo evidence for a 5-hydroxytryptamine (2C) receptor involvement. J Pharmacol Exp Ther 2000, 295: 266-73.
11. Golombek, D.A., Duque, D.F., De Bristo, Sanchez, M.G., Burin, L., Cardinali, D.P. Time-dependent anticonvulsant activity of melatonin in hamsters. Eur J Pharmacol 1991, 210: 253-8.
12. Razia, K., Siddiqui, M.S., Pillai, K.K., Pal, S.N. Antidepressant augmentation with buspirone effects on seizure threshold and brain serotonin levels in mice. Indian J Pharmacol 2001, 33: 198-202.
13. th edition. Hardman, J.G., Limbird, L.E., Goodman, A.G. (Eds.). McGraw-Hill: New York 2001, 461-86.
14. Kasture, S.B., Kasture, B.S. Effect of some serotonergic agents on lithium-pilocarpine model of status epilepticus in rats. Indian J Pharmacol 1999, 31: 370-2.
15. Semenova, T.P., Ticku, M.K. Effects of 5-HT receptor antagonists on seizure susceptibility and locomotor activity in DBA/2 mice. Brain Res 1992, 588: 229-36.
16. Sussman, N. The uses of buspirone in psychiatry. J Clin Psychiatry Monograph 1994; 12: 3-19.
17. 2-adrenoceptors in the rat brain. Eur J Pharmacol 1990, 180: 183-6.
18. 2-adrenoceptors. Eur J Pharmacol 1982, 77: 163-6.
19. 2 receptor function in fibromyalgia patients: A neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. J Affect Disorder 2003, 75: 77-82.
20. Sugimoto, Y., Yamada, S., Yamada, J. The 5-HT2 receptor antagonist reduces immobility of mice treated with the atypical antidepressant mianserin in the forced swimming test. Biol Pharm Bull 2002, 25: 1479-81.
21. th edition. Hardman, J.G., Limbird, L.E., Goodman, A.G. (Eds.), McGraw-Hill: New York 2001, 293-320.
22. 1-adrenoceptors in motor activity in mice. Synapse 2003, 49: 67-76.
23. Ferrari, E., Fraschini, F., Brahmbilla, F. Hormonal circadian rhythm in eating disorders. Biol Psychiatry 1990, 133: 168-71.
24. Roseboom, P.H., Klein, D.C. Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: Primary role of a β-adrenergic receptor cyclic AMP mechanism. Mol Pharmacol 1995, 471: 439-49.
25. Swain, T.R., Mohanty, M. Antiepileptic action of ondansetron. Indian J Pharmacol 1999, 31: 157.
26. Quigg, M., Clayburn, H., Straume, M., Menaker, M., Bertram, E.H. Effects of circadian regulation and rest activity state on spontaneous seizures in a rat model of limbic epilepsy. Epilepsia 2000, 41: 502-9.
27. Niles, L.P., Hashemi, F.S. Pharmacological inhibition offorskolin stimulated adenylate cyclase activity in rat brain by melatonin, its analogs and diazepam. Biochem Pharmacol 1990, 40: 2701-5.
28. Fostermann, U., Heldt, R., Knappen, F., Hertting, G. Partial anti-convulsive properties of endogenous prostaglandins formed in mouse brain. Brain Res 1982, 240: 303-10.
29. Hayase, T., Yamamoto, Y., Yamamoto, K., Fukui, Y. Comparison of effect of ethanol and anticonvulsants on cardiovascular drug-modified cocaine toxicity. Pharmacol Biochem Behav 2000, 67: 151-9.